The Added Value of Contrast-Enhanced 68Ga-FAPI-04 PET/MRI Over 18F-FDG PET/CT in Hepatocellular Carcinoma.
Clin Nucl Med
; 2024 Jun 21.
Article
en En
| MEDLINE
| ID: mdl-38914096
ABSTRACT
ABSTRACT A 43-year-old man with chronic hepatitis B and elevated alpha-fetoprotein levels showed no malignant evidence on 18F-FDG PET/CT. However, subsequent assessment using 68Ga-FAPI-04 PET/MR identified a lesion with increased FAPI uptake in the liver, coupled with detailed enhancement patterns on MRI, leading to a diagnosis of hepatocellular carcinoma, later confirmed by pathology. This case highlights the pivotal role of integrated 68Ga-FAPI-04 PET and enhanced MRI in refining hepatocellular carcinoma diagnostics, advancing a more nuanced imaging approach over conventional modalities for comprehensive evaluation of hepatic lesions.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Idioma:
En
Revista:
Clin Nucl Med
Año:
2024
Tipo del documento:
Article
País de afiliación:
China